stockrow
Friday 6 November 2026
Export AXGN’s income statement to Excel — free account
AxoGen, Inc.
AXGN Healthcare Medical Devices
AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +163.2%
- Free cash flow
- +995.0%
- Total debt
- −73.1%
Quarter to September 2026, against a year earlier
49.73
0.98
+2.01%
Follow AXGN
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 6 | 3 | 2 | 3 | 2 | 2 | 4 | 6 | 4 |
P/S ratio |
6.69 | 3.89 | 1.86 | 3.00 | 3.03 | 6.37 | 6.58 | 9.04 | 15.41 | 6.65 |
Altman Z-Score |
9.23 | 3.65 | 0.54 | 1.47 | 1.68 | 4.98 | 18.00 | 34.32 | 15.18 | 2.87 |
P/FCF ratio |
0.00 | 66,306.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(0.43) | (1.47) | (2.48) | (1.73) | 0.04 | 1.57 | 5.86 | 13.42 | (2.55) | (4.31) |
Beneish M-Score |
(2.73) | (2.83) | (2.69) | (2.54) | (2.80) | (2.40) | (1.66) | (2.04) | (2.20) | (2.21) |
P/Operating CF |
496.12 | 83.50 | (1,404.22) | 305.27 | (255.08) | 252.17 | (210.78) | (152.43) | (887.96) | (187.76) |
P/B ratio |
11.70 | 7.02 | 3.10 | 4.12 | 3.43 | 5.81 | 5.31 | 5.16 | 36.99 | 18.31 |
Price to Tangible BV |
12.34 | 7.42 | 3.25 | 4.27 | 3.52 | 5.91 | 5.37 | 5.20 | 38.42 | 19.39 |
EV/Sales |
6.79 | 4.05 | 2.06 | 3.09 | 2.85 | 5.86 | 5.65 | 7.58 | 15.22 | 6.51 |
EV/EBITDA |
986.66 | 139.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
1,883.41 | 167.27 | (57.40) | (26.65) | (27.10) | (68.39) | (30.33) | (35.61) | (99.54) | (23.81) |
EV/FCF |
(319.81) | 68,961.14 | (15.90) | (11.47) | (8.69) | (20.43) | (24.02) | (26.00) | (87.32) | (21.59) |
Quick Ratio |
3.04 | 2.08 | 2.04 | 3.25 | 4.47 | 5.63 | 5.72 | 10.57 | 3.47 | 3.44 |
Current Ratio |
5.11 | 3.24 | 2.89 | 4.13 | 5.23 | 6.36 | 6.47 | 11.57 | 4.06 | 3.97 |
Net Debt/EBITDA |
14.26 | 5.37 | (2.05) | (0.52) | 1.15 | 2.93 | 3.48 | 6.26 | 1.66 | 0.75 |
Debt/Assets |
30.51% | 33.71% | 34.42% | 34.51% | 32.43% | 26.70% | 2.15% | 0.08% | 41.86% | 52.44% |
Debt/Equity |
0.52 | 0.66 | 0.71 | 0.67 | 0.60 | 0.44 | 0.03 | 0.00 | 0.98 | 1.63 |
Asset Turnover |
1.06 | 0.94 | 0.81 | 0.69 | 0.62 | 0.63 | 0.68 | 0.77 | 1.15 | 0.99 |
Operating CF/Net income |
(0.05) | (0.46) | 0.26 | 0.56 | 0.50 | 0.40 | 0.68 | 0.80 | 0.88 | 0.78 |
Capex/Depreciation |
(0.60) | (0.52) | (2.31) | (3.70) | (5.10) | (6.12) | (1.82) | (7.08) | (1.59) | (2.06) |
Interest Coverage |
(1.02) | (0.40) | (7.57) | (47.61) | (18.74) | (21.99) | (785.15) | (16.97) | (3.23) | (1.30) |
| (13.49%) | (9.99%) | (22.08%) | (27.11%) | (22.90%) | (18.63%) | (20.88%) | (26.02%) | (52.09%) | (124.68%) | |
| (7.38%) | (4.98%) | (11.07%) | (14.35%) | (13.18%) | (13.36%) | (18.51%) | (20.45%) | (19.85%) | (34.70%) | |
ROIC |
(3.25%) | (1.54%) | (10.61%) | (16.37%) | (17.72%) | (21.92%) | (59.53%) | (52.30%) | (37.30%) | (55.12%) |
Return on Tangible Assets |
(8.79%) | (6.50%) | (14.84%) | (18.84%) | (16.29%) | (14.79%) | (22.58%) | (15.35%) | (23.62%) | (41.83%) |
Average Days of Receivables |
42.41 | 46.97 | 57.72 | 58.43 | 52.04 | 57.26 | 57.96 | 66.62 | 66.84 | 71.50 |
Research and Development Expense of Revenue |
14.60% | 14.82% | 17.19% | 18.49% | 18.98% | 15.89% | 16.41% | 14.03% | 11.09% | 10.25% |
Selling, General and Administrative Expense of Revenue |
63.19% | 62.72% | 72.95% | 81.46% | 82.97% | 85.53% | 96.76% | 95.00% | 86.66% | 93.80% |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
13.37% | 8.49% | 9.07% | 11.25% | 8.57% | 7.54% | 9.66% | 9.06% | 5.97% | 3.38% |
Graham Net Nets |
0.02 | 0.00 | (0.04) | 0.01 | 0.08 | 0.09 | 0.16 | 0.18 | 0.02 | 0.05 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1.02%) | (1.33%) | (7.53%) | (6.88%) | (6.94%) | (3.35%) | (4.14%) | (2.94%) | (1.07%) | (5.17%) |
Free Cash Flow Yield |
(0.32%) | 0.00% | (6.96%) | (8.98%) | (10.83%) | (4.50%) | (3.58%) | (3.23%) | (1.13%) | (4.54%) |
Revenue per Share |
4.89 | 4.23 | 3.71 | 3.29 | 3.09 | 2.81 | 2.72 | 2.26 | 1.81 | 1.34 |
Operating CF per Share |
0.02 | 0.10 | (0.13) | (0.38) | (0.33) | (0.24) | (0.51) | (0.48) | (0.28) | (0.37) |
Capex per Share |
(0.12) | (0.10) | (0.35) | (0.50) | (0.69) | (0.57) | (0.13) | (0.18) | (0.04) | (0.04) |
Free Cash Flow per Share |
(0.10) | 0.00 | (0.48) | (0.89) | (1.01) | (0.81) | (0.64) | (0.66) | (0.32) | (0.40) |
Cash per Share |
0.99 | 0.89 | 0.86 | 1.31 | 2.19 | 2.77 | 2.61 | 3.30 | 1.10 | 0.98 |
Shareholders Equity per Share |
2.80 | 2.35 | 2.23 | 2.40 | 2.73 | 3.08 | 3.37 | 3.96 | 0.76 | 0.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.80 | 2.35 | 2.23 | 2.40 | 2.73 | 3.08 | 3.37 | 3.96 | 0.76 | 0.49 |
Free Cash Flow |
(4.78) | 0.01 | (20.63) | (37.32) | (41.80) | (32.22) | (25.10) | (24.46) | (10.53) | (12.39) |
Working Capital |
96.87 | 68.61 | 57.57 | 74.32 | 102.76 | 122.42 | 114.14 | 137.91 | 42.02 | 32.96 |
Capital Expenditures |
(5.59) | (4.52) | (14.92) | (21.25) | (28.40) | (22.60) | (5.23) | (6.60) | (1.29) | (1.16) |
Net Current Asset Value |
27.58 | (0.60) | (13.16) | 3.69 | 31.58 | 67.02 | 112.53 | 137.76 | 22.05 | 12.60 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.09 | 0.15 | 0.22 | 0.20 | 0.05 | 0.08 | 0.02 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.11 | 0.10 | 0.07 | 0.07 | 0.09 | 0.10 | 0.19 | 0.12 | 0.37 | 0.38 |
Cash ROIC |
(1.98%) | 0.01% | (10.29%) | (16.70%) | (15.46%) | (11.20%) | (10.55%) | (9.07%) | (12.20%) | (17.90%) |
Accounts Receivable Turnover |
8.96 | 7.61 | 6.72 | 6.87 | 7.12 | 6.50 | 6.61 | 6.36 | 6.32 | 6.41 |
Accounts Payable Turnover |
2.32 | 1.58 | 1.45 | 1.33 | 1.03 | 1.05 | 1.08 | 1.18 | 1.17 | 1.21 |
Inventory Turnover |
1.53 | 1.61 | 1.77 | 1.67 | 1.57 | 1.64 | 1.34 | 1.34 | 1.46 | 1.38 |
Average Days of Payables |
133.65 | 230.46 | 283.83 | 275.12 | 357.49 | 371.55 | 402.76 | 367.12 | 350.93 | 395.21 |
Days of Inventory on Hand |
267.33 | 267.01 | 226.21 | 231.75 | 265.71 | 211.90 | 291.62 | 338.42 | 286.79 | 308.10 |
Average Receivables |
25.14 | 24.63 | 23.67 | 20.17 | 17.89 | 17.28 | 16.13 | 13.19 | 9.56 | 6.42 |
Average Payables |
24.91 | 28.76 | 25.66 | 22.45 | 22.21 | 20.56 | 16.07 | 10.98 | 7.98 | 5.35 |
Average Inventory |
37.78 | 28.10 | 20.96 | 17.80 | 14.61 | 13.20 | 12.92 | 9.65 | 6.39 | 4.70 |
Average Assets |
212.71 | 200.28 | 196.11 | 201.71 | 204.70 | 178.01 | 157.41 | 109.52 | 52.62 | 41.53 |
Average Common Equity |
116.38 | 99.79 | 98.33 | 106.77 | 117.85 | 127.65 | 139.57 | 86.08 | 20.05 | 11.56 |
Columns are period end dates · fundamentals updated 5 Nov 2026